Heart transplantation: a thirty-year perspective.
Heart transplantation has evolved over the past 30 years into a mainstay of therapy for heart failure patients. As the surgical technique and basic immunology were defined, heart transplantation became a real therapeutic option. Over the next few decades, thoracic transplant teams at Stanford University and other institutions refined this mode of therapy. This review addresses the history, current surgical technique, recipient and donor selection, postoperative care, immunosuppression, short- and long-term complications, and clinical outcomes associated with this procedure.
Miniati
Douglas N
DN
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, 94025, USA. dminiati@leland.stanford.edu
Robbins
Robert C
RC
D002423:Cause of Death; D005544:Forecasting; D006333:Heart Failure / Q000401:mortality / Q000601:surgery*; D016027:Heart Transplantation / Q000639:trends*; D006801:Humans; D007165:Immunosuppression Therapy / Q000639:trends; D010043:Outcome and Process Assessment, Health Care; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D014019:Tissue Donors / Q000600:supply & distribution